CLVS250117P2000
- 1.10
- 0.000.00%
Clovis Oncology Newsroom
Clovis Oncology (NASDAQ:CLVSQ) Versus Oncotelic Therapeutics (OTCMKTS:OTLC) Head-To-Head Contrast
Clovis Oncology (NASDAQ:CLVSQ – Get Rating) and Oncotelic Therapeutics (OTCMKTS:OTLC – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two co
Clovis Oncology (CLVSQ) & Its Peers Head to Head Survey
Clovis Oncology (NASDAQ:CLVSQ – Get Rating) is one of 981 public companies in the "Pharmaceutical preparations" industry, but how does it contrast to its competitors? We will compare Clovis Oncology t
Financial Contrast: Clovis Oncology (CLVSQ) Versus Its Competitors
Clovis Oncology (NASDAQ:CLVSQ – Get Rating) is one of 981 public companies in the "Pharmaceutical preparations" industry, but how does it weigh in compared to its competitors? We will compare Clovis O
Clovis Oncology (NASDAQ:CLVS) Research Coverage Started at StockNews.com
Equities research analysts at StockNews.com initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research report issued on Thursday. The brokerage set a "hold" rating on th
Clovis Oncology (NASDAQ:CLVS) Earns Hold Rating From Analysts at StockNews.com
StockNews.com initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research note issued to investors on Tuesday. The firm issued a hold rating on the biopharmaceutical comp
Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S From The Nasdaq Stock Market
NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, unit, and warrant of Tuscan Holdings Corp. II. Tuscan Holdings Corp. II's securities were
Clovis Oncology (NASDAQ:CLVS) Now Covered by StockNews.com
StockNews.com began coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research report sent to investors on Monday. The firm issued a hold rating on the biopharmaceutical company's
Zacks.com Featured Highlights Include Clovis Oncology, NiSource, DocuSign, Root and Endava
Express News | News On Clovis Oncology Inc. (CLVS) Now Under CLVSQ
StockNews.com Initiates Coverage on Clovis Oncology (NASDAQ:CLVS)
Analysts at StockNews.com began coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research note issued to investors on Monday. The firm set a "hold" rating on the biopharmaceutica
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersPLx Pharma (NASDAQ:PLXP) stock increased by 10.6% to $0.23 during Wednesday's after-market session. The market value of their outstanding shares is at $6.5 million. Clovis Oncology (NASDAQ:CLVS
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.Crown ElectroKinetics C
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 49 companies hit new 52-week lows. Key Facts About Today's 52-Week Lows: Tesla (NASDAQ:TSLA) is the largest company in terms of market cap to set a new 52-week low this morning.The sma
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOpGen (NASDAQ:OPGN) stock increased by 242.3% to $0.43 during Tuesday's regular session. OpGen's stock is trading at a volume of 169.2 million shares as of 12:30 EST. This is 40400.7% of its av
Novartis Bids $681 Million To Buy Cancer Drug From Bankruptcy Filer Clovis Oncology
10:26 PM EST, 12/12/2022 (MT Newswires) -- A Novartis (NOVN.SW) unit offered up to $680.8 million to buy Clovis Oncology's experimental cancer drug as the latter filed for bankruptcy in the US on Mond
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis -- WSJ
By Jonathan Randles Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer ther
Stocks That Hit 52-Week Lows On Monday
 Monday saw 196 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Brookfield Asset Mgmt (NYSE:BAM
Cancer Focused Clovis Oncology Files For Bankruptcy
Clovis Oncology Inc (NASDAQ:CLVS) has voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.The Debtors h
Clovis Stock Slumps Amid Chapter 11 Filing, to Sell FAP-2286 to Novartis for $50M Upfront
Clovis Oncology Files for Chapter 11 Protection, and Says It Will Sell Assets
Clovis Oncology Files for Chapter 11 Protection, and Says It Will Sell Assets